Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6–35 Months: A Randomized, Controlled Trial

BACKGROUND. Improved influenza vaccine strategies for infants and preschool children are a high priority. METHODS. The immunological response and safety of a thimerosal-free trivalent inactivated influenza vaccine at 2 different doses (0.50 mL vs 0.25 mL) was evaluated in children aged 6–35 months....

Descripción completa

Detalles Bibliográficos
Autores principales: Langley, Joanne M., Vanderkooi, Otto G., Garfield, Hartley A., Hebert, Jacques, Chandrasekaran, Vijayalakshmi, Jain, Varsha K., Fries, Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Original Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656551/
https://www.ncbi.nlm.nih.gov/pubmed/23687572
http://dx.doi.org/10.1093/jpids/pis012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656551/
https://www.ncbi.nlm.nih.gov/pubmed/23687572
http://dx.doi.org/10.1093/jpids/pis012

Ejemplares similares